Identification of Novel Bacteriophages with Therapeutic Potential That Target Enterococcus faecalis

Authors: M. Al-Zubidi, Magdalena Widziołek, Elizabeth K. Court, Ashley F. Gains, Robert E. Smith, Katherine Ansbro, Alhassan Alrafaie, Caroline A. Evans, Craig Murdoch, Stéphane Mesnage, C.W.I. Douglas, Āndrew Rawlinson, Graham P. Stafford - Infection and Immunity 2019 cited by 86

The Gram-positive opportunistic pathogen Enterococcus faecalis is frequently responsible for nosocomial infections in humans and represents one of the most common bacteria isolated from recalcitrant endodontic (root canal) infections. E. faecalis is intrinsically resistant to several antibiotics routinely used in clinical settings (such as cephalosporins and aminoglycosides) and can acquire resistance to vancomycin (vancomycin-resistant enterococci).